Brief: Guerbet Announces Approval For Lipiodol Ultra‐Fluide In Denmark
Nov 19 (Reuters) - Guerbet SA GRBT.PA :
* LIPIODOL ULTRA‐FLUIDE IS NOW AUTHORIZED IN DENMARK IN
CONVENTIONAL TRANS-ARTERIAL CHEMOEMBOLIZATION OF MID-STAGE
HEPATOCELLULAR CARCINOMA
Source text : https://bit.ly/2D0mrPq
Further company coverage: GRBT.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))
Recent news on Guerbet SA
See all newsBrief: Guerbet Revenue At 30 September 2026 Of EUR 573.8 Million
Corrected: French medical imaging firm Guerbet's 9M revenue slips on China sales drop
French medical imaging firm Guerbet H1 EBITDA margin falls on Raleigh site costs
Brief: Guerbet H1 EBITDA €30.6 Mln
French and Benelux stocks-Factors to watch